{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:10:15Z","timestamp":1761196215921},"reference-count":24,"publisher":"Wiley","issue":"1-2","license":[{"start":{"date-parts":[[2001,4,19]],"date-time":"2001-04-19T00:00:00Z","timestamp":987638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FEBS Letters"],"published-print":{"date-parts":[[2001,4,20]]},"abstract":"<jats:p>We recently reported the molecular identification of a new type of receptor for the neuropeptide neurotensin (NT), the neurotensin receptor 3 (NTR3), identical to sortilin, which binds receptor\u2010associated protein. Here, we demonstrate that the cloned mouse NTR3 is expressed on the plasma membrane of transfected COS\u20107 cells. The mouse NTR3 is detectable by photoaffinity labeling and immunoblotting at the cell surface as a 100 kDa <jats:italic>N<\/jats:italic>\u2010glycosylated protein. Biochemical analysis and confocal microscopic imaging clearly indicate that NT is efficiently internalized after binding to NTR3, and that despite this internalization, the amount of receptor present on the cell surface is maintained.<\/jats:p>","DOI":"10.1016\/s0014-5793(01)02367-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:18:16Z","timestamp":1027617496000},"page":"100-105","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin"],"prefix":"10.1002","volume":"495","author":[{"given":"Val\u00e9rie","family":"Navarro","sequence":"first","affiliation":[]},{"given":"St\u00e9phane","family":"Martin","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Sarret","sequence":"additional","affiliation":[]},{"given":"Morten S.","family":"Nielsen","sequence":"additional","affiliation":[]},{"given":"Claus M.","family":"Petersen","sequence":"additional","affiliation":[]},{"given":"Jean-Pierre","family":"Vincent","sequence":"additional","affiliation":[]},{"given":"Jean","family":"Mazella","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2001,4,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(90)90137-5"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-18-05613.1996"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00397-3"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.41.26273"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.6.3599"},{"key":"e_1_2_6_7_1","first-page":"1025","volume":"379","author":"Willnow T.E.","year":"1998","journal-title":"Biol. Chem."},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.3.595"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.13.8832"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63010019.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.8071"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(92)90126-V"},{"key":"e_1_2_6_13_1","first-page":"470","volume":"46","author":"Yamada M.","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.6.2439"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.39.24145"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.6.3582"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(84)80179-5"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)85313-9"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.5.2880"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(87)52074-2"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)38365-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)83582-7"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.36.21703"},{"key":"e_1_2_6_25_1","unstructured":"Dal Farra C. Sarret P. Navarro V. Botto J.M. Mazella J. and Vincent J.P. (2001) Int. J. Cancer (in press)."}],"container-title":["FEBS Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2FS0014-5793%2801%2902367-5","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2FS0014-5793(01)02367-5","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/S0014-5793%2801%2902367-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T04:37:22Z","timestamp":1694925442000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1016\/S0014-5793%2801%2902367-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,19]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2001,4,20]]}},"alternative-id":["10.1016\/S0014-5793(01)02367-5"],"URL":"https:\/\/doi.org\/10.1016\/s0014-5793(01)02367-5","archive":["Portico"],"relation":{},"ISSN":["0014-5793","1873-3468"],"issn-type":[{"value":"0014-5793","type":"print"},{"value":"1873-3468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,19]]}}}